A cell-penetrating peptide-assisted nanovaccine promotes antigen cross-presentation and anti-tumor immune response
Keyword(s):
Mhc I
◽
Exogenous antigens processed in the cytosol and subsequently cross-presented on major histocompatibility complex class I (MHC-I) molecules activate cytotoxic CD8+ lymphocytes (CTL), which are crucial in cancer immunotherapy.
2012 ◽
Vol 513
(2)
◽
pp. 223-228
◽
2013 ◽
Vol 288
(45)
◽
pp. 32797-32808
◽
2000 ◽
Vol 74
(19)
◽
pp. 9256-9266
◽
2013 ◽
Vol 172
(2)
◽
pp. 280-289
◽
2002 ◽
Vol 76
(2)
◽
pp. 633-643
◽
2004 ◽
Vol 85
(10)
◽
pp. 2809-2814
◽
2020 ◽